Nutex Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	-45.79	-424.78	132.59	105.97	-7.12	-0.95	0.58	-7.43
Depreciation & Amortization	17.72	13.2	7.76	5.96	0.17	0	0.54	0
Share-Based Compensation	2.84	0.19	0	0	0.45	0.16	0.92	0
Other Operating Activities	26.48	462	33.08	-25.25	2.45	0.31	-2.76	7.16
Operating Cash Flow	1.26	50.61	173.43	86.67	-4.04	-0.48	-0.71	-0.27
Operating Cash Flow Growth	-97.52%	-70.82%	100.10%	-	-	-	-	-
Capital Expenditures	-9.5	-14.63	-36.93	-61.19	-0.08	0	0	0
Acquisitions	-1.74	10.3	-0.05	0	-0.56	-0.12	-0.03	0
Other Investing Activities	-	-	-	-	-0.1	-	0.03	-0.01
Investing Cash Flow	-11.24	-4.34	-36.98	-61.19	-0.75	-0.12	0	-0.01
Share Issuance / Repurchase	0	0	0	0	4.11	0	0.28	0
Debt Issued / Paid	2.65	-5.59	-3.27	41.05	1.62	0.34	0.46	0.05
Other Financing Activities	-4.92	-42.54	-122.58	-49.02	-	0.37	-0.02	0.12
Financing Cash Flow	-2.27	-48.13	-125.85	-7.97	5.73	0.7	0.71	0.17
Net Cash Flow	-12.25	-1.86	10.6	17.51	0.95	0.11	-0	-0.11
Free Cash Flow	-8.24	35.97	136.51	25.48	-4.12	-0.48	-0.71	-0.27
Free Cash Flow Growth	-	-73.65%	435.67%	-	-	-	-	-
Free Cash Flow Margin	-3.33%	16.40%	41.17%	9.30%	-301.85%	-35.12%	-3084.79%	-
Free Cash Flow Per Share	-0.18	0.83	54.86	77.34	-17.04	-4.23	-64.06	-51.82

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).